[1] |
SERRADILLA MARTÍN M, OLIVER GUILLÉN JR, PALOMARES CANO A, et al. Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma[J]. Rev Esp Enferm Dig, 2020, 112(2): 133-138.
|
[2] |
XIAO WS, LE YY, ZENG SL, et al. Research advances in the pathogenesis of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(8): 1874-1879. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.08.043
肖伟松, 乐滢玉, 曾胜澜, 等. 非酒精性脂肪性肝病的发病机制研究进展[J]. 临床肝胆病杂志, 2020, 36(8): 1874-1879. DOI: 10.3969/j.issn.1001-5256.2020.08.043
|
[3] |
WU J, SUN M. Diagnosis and treatment of non-alcoholic fatty liver disease in children[J]. J Appl Clin Pediatr, 2019, 34(19): 1441-1444. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-CRBX201902018.htm
吴捷, 孙梅. 儿童非酒精性脂肪性肝病的诊治进展[J]. 中华实用儿科临床杂志, 2019, 34(19): 1441-1444. https://www.cnki.com.cn/Article/CJFDTOTAL-CRBX201902018.htm
|
[4] |
TORUN E, GÖNÜLLÜ E, OZGEN IT, et al. Vitamin d deficiency and insufficiency in obese children and adolescents and its relationship with insulin resistance[J]. Int J Endocrinol, 2013, 2013: 631845. http://pubmedcentralcanada.ca/pmcc/articles/PMC3623428/?report=abstract
|
[5] |
MANSON JE, COOK NR, LEE IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease[J]. N Engl J Med, 2019, 380(1): 33-44. DOI: 10.1056/NEJMoa1809944
|
[6] |
CHAROENNGAM N, HOLICK MF. Immunologic effects of vitamin D on human health and disease[J]. Nutrients, 2020, 12(7): 2097. DOI: 10.3390/nu12072097
|
[7] |
BOREL P, CAILLAUD D, CANO NJ. Vitamin D bioavailability: State of the art[J]. Crit Rev Food Sci Nutr, 2015, 55(9): 1193-1205. DOI: 10.1080/10408398.2012.688897
|
[8] |
GULSETH HL, GJELSTAD IM, BIRKELAND KI, et al. Vitamin D and the metabolic syndrome[J]. Curr Vasc Pharmacol, 2013, 11(6): 968-984. DOI: 10.2174/15701611113119990169
|
[9] |
LU Z, PAN X, HU Y, et al. Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women[J]. Clin Exp Pharmacol Physiol, 2015, 42(2): 139-145. DOI: 10.1111/1440-1681.12334
|
[10] |
LIU T, XU L, CHEN FH, et al. Association of serum vitamin D level and nonalcoholic fatty liver disease: A meta-analysis[J]. Eur J Gastroenterol Hepatol, 2020, 32(2): 140-147. DOI: 10.1097/MEG.0000000000001486
|
[11] |
GIBSON PS, QUAGLIA A, DHAWAN A, et al. Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease[J]. Pediatr Obes, 2018, 13(7): 433-441. DOI: 10.1111/ijpo.12293
|
[12] |
SEZER OB, BULUŞ D, HIZLI Ş, et al. Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children[J]. J Pediatr Endocrinol Metab, 2016, 29(7): 783-788. DOI: 10.1515/jpem-2015-0426
|
[13] |
STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25(9): 603-605. DOI: 10.1007/s10654-010-9491-z
|
[14] |
CHANG EJ, YI DY, YANG HR. Vitamin D status and bone mineral density in obese children with nonalcoholic fatty liver disease[J]. J Korean Med Sci, 2015, 30(12): 1821-1827. DOI: 10.3346/jkms.2015.30.12.1821
|
[15] |
YILDIZ I, EROL OB, TOPRAK S, et al. Role of vitamin D in children with hepatosteatosis[J]. J Pediatr Gastroenterol Nutr, 2014, 59(1): 106-111. DOI: 10.1097/MPG.0000000000000371
|
[16] |
PIRGON O, CEKMEZ F, BILGIN H, et al. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease[J]. Obes Res Clin Pract, 2013, 7(4): e275-283. DOI: 10.1016/j.orcp.2012.01.004
|
[17] |
MOHAMED AHMED A, ABDEL GHANY M, ABDEL HAKEEM GL, et al. Assessment of vitamin D status in a group of Egyptian children with nonalcoholic fatty liver disease[J]. Nutr Metab (Lond), 2016, 13: 53. DOI: 10.1186/s12986-016-0112-z
|
[18] |
MALESPIN M, SLEESMAN B, LAU A, et al. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children[J]. J Clin Gastroenterol, 2015, 49(4): 345-349. DOI: 10.1097/MCG.0000000000000121
|
[19] |
BLACK LJ, JACOBY P, SHE PING-DELFOS WC, et al. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity[J]. J Gastroenterol Hepatol, 2014, 29(6): 1215-1222. DOI: 10.1111/jgh.12541
|
[20] |
NOBILI V, GIORGIO V, LICCARDO D, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease[J]. Eur J Endocrinol, 2014, 170(4): 547-553. DOI: 10.1530/EJE-13-0609
|
[21] |
HU Y, ZHOU Y, HE JX, et al. Effect of serum level change of 25-(OH) D3 and IL-17 in obesity children with NAFLD[J]. Chin J Health Lab Technol, 2018, 28(3): 323-325. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201803021.htm
胡颖, 周莹, 何继新, 等. 血清25-羟维生素D3和IL-17水平变化在肥胖儿童非酒精性脂肪肝病进展中的作用[J]. 中国卫生检验杂志, 2018, 28(3): 323-325. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201803021.htm
|
[22] |
ZHANG LH, SHAO Q, XIA ZJ. Changes of serum 25-(OH) D3 and IL-17 levels are associated with progress of nonalcoholic fatty liver disease in obese children[J]. J Prac Hepatol, 2019, 22(4): 522-525. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-GBSY201904018.htm
张兰华, 邵琴, 夏振娟. 非酒精性脂肪性肝病儿童血清25-(OH)D3和IL-17水平变化初步研究[J]. 实用肝脏病杂志, 2019, 22(4): 522-525. https://www.cnki.com.cn/Article/CJFDTOTAL-GBSY201904018.htm
|
[23] |
ZHOU XL, FU JF. Expert consensus on the diagnosis and treatment of nonalcoholic fatty liver disease in children[J]. Chin J Pract Pediatr, 2018, 33(7): 487-492. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201807002.htm
周雪莲, 傅君芬. 儿童非酒精性脂肪肝病诊断与治疗专家共识[J]. 中国实用儿科杂志, 2018, 33(7): 487-492. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201807002.htm
|
[24] |
CHALASANI N, YOUNOSSI Z, LAVINE JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J]. Hepatology, 2012, 55(6): 2005-2023. DOI: 10.1002/hep.25762
|
[25] |
SHAUNAK M, BYRNE CD, DAVIS N, et al. Non-alcoholic fatty liver disease and childhood obesity[J]. Arch Dis Child, 2021, 106(1): 3-8. DOI: 10.1136/archdischild-2019-318063
|
[26] |
AQUINO S, CUNHA A, LIMA JG, et al. Effects of vitamin D supplementation on fasting glucose, dyslipidemia, blood pressure, and abdominal obesity among patients with metabolic syndrome: A protocol for systematic review and meta-analysis of randomized controlled trials[J]. Syst Rev, 2020, 9(1): 176. DOI: 10.1186/s13643-020-01433-3
|
[27] |
GOLDNER WS, STONER JA, THOMPSON J, et al. Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: A comparison with non-obese controls[J]. Obes Surg, 2008, 18(2): 145-150. DOI: 10.1007/s11695-007-9315-8
|
[28] |
ROSENBLUM JL, CASTRO VM, MOORE CE, et al. Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults[J]. Am J Clin Nutr, 2012, 95(1): 101-108. DOI: 10.3945/ajcn.111.019489
|
[29] |
QU YL, WANG YC, WAN JX. Association of nonalcoholic fatty liver disease with vitamin D and bone mineral density[J]. J Clin Hepatol, 2019, 35(9): 2021-2025. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.09.027
曲玉蕾, 王迎春, 万金鑫. 非酒精性脂肪性肝病与血清维生素D及骨密度的关系[J]. 临床肝胆病杂志, 2019, 35(9): 2021-2025. DOI: 10.3969/j.issn.1001-5256.2019.09.027
|
[30] |
MAI XM, CHEN Y, CAMARGO CA Jr, et al. Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study[J]. Am J Epidemiol, 2012, 175(10): 1029-1036. DOI: 10.1093/aje/kwr456
|
[31] |
LUKENDA ZANKO V, DOMISLOVIC V, TRKULJA V, et al. Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial[J]. Diabetes Obes Metab, 2020, 22(11): 2097-2106. DOI: 10.1111/dom.14129
|